🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.

Some professionals stated the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Service Reaction and Content Removal

According to TikTok, the platform has taken down violative content and prohibited associated keywords and search suggestions. The organization said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

After minutes of joining one group, a seller posted contact information, where most purchases occur. The vendor sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these communities, posts show dark colored parcels with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may subject users to possibly significant health risks”.